760178

544709

GAUDIUMIVF

img img img img
No Data Available

Gaudium IVF and Women Health Ltd Share Price Update

As of the latest trading session, Gaudium IVF and Women Health Ltd share price is currently at ₹96.91, which is down by ₹-7.20 from its previous closing. Today, the stock has fluctuated between ₹96.10 and ₹108.00. Over the past year, Gaudium IVF and Women Health Ltd has achieved a return of [-]%. In the last month alone, the return has been 14.01%.

Gaudium IVF and Women Health Ltd performance

Today’s low

Today’s high

₹ 96.10 ₹ 108.00
₹ 96.91

52 week low

52 week high

₹ 69.18 ₹ 108.00
₹ 96.91

Open Price

₹ 105.99

Prev. Close

₹ 104.12

Volume (Shares)

2437045.00

Total traded value

₹ 2361.74

Upper Circuit

₹ 124.94

Lower Circuit

₹ 83.30

info

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Gaudium IVF and Women Health Ltd fundamentals


  • Market cap (Cr)

    705.40

  • P/E Ratio (TTM)

    34.11

  • Beta

    1.75

  • Book Value / share

    18.60

  • Return on equity

    51.57%

  • EPS (TTM)

    2.85

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    3.18

info icon alternate text
  • Market cap (Cr)

    707.60

  • P/E Ratio (TTM)

    34.11

  • Beta

    1.72

  • Book Value / share

    18.60

  • Return on equity

    51.57%

  • EPS (TTM)

    2.85

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    3.18

info icon alternate text

Gaudium IVF and Women Health Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 14.19
Operating Expense 9.95
Net Profit 3.18
Net Profit Margin (%) 22.41
Earnings Per Share (EPS) 0.52
EBITDA 5.93
Effective Tax Rate (%) 26.66
Particulars SEP 2025 (Values in Cr)
Revenue 22.95
Operating Expense 10.77
Net Profit 9.03
Net Profit Margin (%) 39.34
Earnings Per Share (EPS) 1.47
EBITDA 13.40
Effective Tax Rate (%) 26.66
Particulars JUN 2025 (Values in Cr)
Revenue 12.27
Operating Expense 0.00
Net Profit 2.35
Net Profit Margin (%) 19.15
Earnings Per Share (EPS) 0.38
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 16.82
Operating Expense 0.00
Net Profit 6.21
Net Profit Margin (%) 36.92
Earnings Per Share (EPS) 1.01
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 13.95
Operating Expense 9.32
Net Profit 3.35
Net Profit Margin (%) 24.01
Earnings Per Share (EPS) 0.55
EBITDA 5.58
Effective Tax Rate (%) 27.70
Particulars MAR 2025 (Values in Cr)
Revenue 59.00
Operating Expense 34.54
Net Profit 18.63
Net Profit Margin (%) 31.57
Earnings Per Share (EPS) 3.06
EBITDA 28.10
Effective Tax Rate (%) 24.53
Particulars MAR 2024 (Values in Cr)
Revenue 52.22
Operating Expense 29.65
Net Profit 16.64
Net Profit Margin (%) 31.86
Earnings Per Share (EPS) 168.04
EBITDA 25.34
Effective Tax Rate (%) 27.14
Particulars MAR 2023 (Values in Cr)
Revenue 44.01
Operating Expense 26.08
Net Profit 13.26
Net Profit Margin (%) 30.12
Earnings Per Share (EPS) 133.93
EBITDA 19.66
Effective Tax Rate (%) 26.12
Particulars MAR 2025 (Values in Cr)
Book Value / Share 7.54
ROE % 52.20
ROCE % 48.32
Total Debt to Total Equity 0.52
EBITDA Margin 41.16
Particulars MAR 2024 (Values in Cr)
Book Value / Share 272.53
ROE % 41.51
ROCE % 44.10
Total Debt to Total Equity 0.58
EBITDA Margin 41.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 229.54
ROE % 84.45
ROCE % 74.77
Total Debt to Total Equity 0.55
EBITDA Margin 45.75
Particulars MAR 2022 (Values in Cr)
Book Value / Share 93.86
ROE % 95.05
ROCE % 80.98
Total Debt to Total Equity 0.64
EBITDA Margin 37.05
Particulars MAR 2025 (Values in Cr)
Book Value / Share 7.40
ROE % 51.57
ROCE % 47.49
Total Debt to Total Equity 0.53
EBITDA Margin 48.02
Particulars MAR 2024 (Values in Cr)
Book Value / Share 269.26
ROE % 40.13
ROCE % 43.93
Total Debt to Total Equity 0.55
EBITDA Margin 41.68
Particulars MAR 2023 (Values in Cr)
Book Value / Share 230.56
ROE % 58.08
ROCE % 55.58
Total Debt to Total Equity 0.43
EBITDA Margin 44.99
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 7.21
Total Assets 88.51
Total Liabilities 88.51
Total Equity 46.29
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 21.60
Return on Capital (%) 29.32
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 11.85
Total Assets 57.29
Total Liabilities 57.29
Total Equity 33.26
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 28.97
Return on Capital (%) 33.88
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 15.05
Total Assets 36.62
Total Liabilities 36.62
Total Equity 22.72
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 36.92
Return on Capital (%) 41.6
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.57
Total Assets 17.77
Total Liabilities 17.77
Total Equity 9.29
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 49.67
Return on Capital (%) 57.92
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 6.72
Total Assets 74.97
Total Liabilities 74.97
Total Equity 45.43
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 24.79
Return on Capital (%) 28.88
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 11.64
Total Assets 50.80
Total Liabilities 50.80
Total Equity 26.66
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 19.54
Return on Capital (%) 23.42
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 14.78
Total Assets 35.00
Total Liabilities 35.00
Total Equity 22.82
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 37.88
Return on Capital (%) 40.7
Particulars MAR 2025 (Values in Cr)
Net Income 25.60
Cash from Operations 13.40
Cash from Investing -15.17
Cash from Financing 1.81
Net change in Cash -4.64
Free Cash Flow 22.28
Particulars MAR 2024 (Values in Cr)
Net Income 16.92
Cash from Operations 5.26
Cash from Investing -5.40
Cash from Financing -1.24
Net change in Cash -3.20
Free Cash Flow 8.05
Particulars MAR 2023 (Values in Cr)
Net Income 18.22
Cash from Operations 28.60
Cash from Investing -15.62
Cash from Financing 5.25
Net change in Cash 13.48
Free Cash Flow 43.85
Particulars MAR 2022 (Values in Cr)
Net Income 11.99
Cash from Operations 1.70
Cash from Investing -1.36
Cash from Financing 2.79
Net change in Cash 0.42
Free Cash Flow 3.07
Particulars MAR 2025 (Values in Cr)
Net Income 24.88
Cash from Operations 13.04
Cash from Investing -15.17
Cash from Financing 1.81
Net change in Cash -4.91
Free Cash Flow 21.91
Particulars MAR 2024 (Values in Cr)
Net Income 22.83
Cash from Operations 2.36
Cash from Investing -2.75
Cash from Financing -0.99
Net change in Cash -3.14
Free Cash Flow 5.12
Particulars MAR 2023 (Values in Cr)
Net Income 17.94
Cash from Operations 28.64
Cash from Investing -14.47
Cash from Financing 3.50
Net change in Cash 13.04
Free Cash Flow 41.86
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7699.05 60.94 12.18 110700.53 6680.00 8099.00
FORTIS MALAR HOSPITALS LIMITED 57.05 23.57 3.11 106.92 40.75 86.90
SHREE PACETRONIX LTD. 143.34 21.62 3.16 53.75 66.10 283.15
TRANSGENE BIOTEK LTD. 3.10 0.00 2.55 23.49 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7699.05 76.22 11.88 110700.53 6680.00 8099.00
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 43.97 0.00 -12.77 32.85 30.02 57.48
KOVAI MEDICAL CENTER & HOSPITA 5420.60 25.15 4.98 5930.14 5010.00 6725.00

Gaudium IVF and Women Health Ltd shareholding pattern

Holding

14.36%
71.29%
9.24%
5.1%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Gaudium IVF and Women Health Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
96.91 -6.92 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 96.60
  • 26 Days 85.60
  • 10 Days 91.80
  • 50 Days 82.60
  • 12 Days 90.50
  • 100 Days 82.60
  • 20 Days 87.20
  • 200 Days 82.60
102.45 PIVOT

First Support

98.09

First Resistance

108.47

Second Support

92.07

Second Resistance

112.83

Third Support

87.71

Third Resistance

118.85

RSI

61.07

ADX

19.30

MACD

4.88

Williams % R

-29.97

Commodity Channel Index (CCI)

127.79

Date

2026-04-17

Week

1179079.00

Same Day

1006595.00

Month

712814.00

1 Year

1.76

3 Year

1.75

Over 1 Month

14.01%

down

Over 1 Year

0.00%

down

Over 3 Months

20.74%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Gaudium IVF and Women Health Ltd Corporate Actions

Top Gainers

Gaudium IVF and Women Health Ltd Share Price

Gaudium IVF and Women Health Limited was originally incorporated in the name of 'Gaudium IVF and Women Health Private Limited' as a Private Limited Company, dated March 24, 2015 with the RoC, Delhi and Haryana. Subsequently, the status of the Company was converted from a Private Limited into a Public Limited and the name was changed to Gaudium IVF and Women Health Limited', and a fresh Certificate of Incorporation dated October 24, 2024 was issued by the Central Processing Center.

Company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. Gaudium IVF is founded by the Promoter Dr. Manika Khanna, a specialist with advanced training in gynecological endoscopic surgery from Kiel, Germany, and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited. The Company offer a complete array of specialized fertility and reproductive health services. Their treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI) and ovulation induction, all treatment is carefully designed to address a variety of infertility challenges for both male and female.

Its facilities provide a comprehensive range of male infertility treatments, including advanced sperm retrieval techniques. For fertility preservation, Company offer cryopreservation services for eggs freezing for future fertilization, utilizing advanced technology to ensure optimal success rates in future IVF cycles. It further provide laparoscopic and hysteroscopic surgeries for the diagnosis and treatment of infertility-related conditions, as well as genetic testing options, including Preimplantation Genetic Testing (PGT), designed to enhance pregnancy outcomes and mitigate the risks of genetic disorders.

The Company began its journey by starting the business operations at Gaudium Hospital in 2019. Gaudium IVF and Gynae Solutions, a proprietary firm of Dr. Manika Khanna, was acquired by the Company with the main object clause, pursuant to a preferential allotment dated March 29, 2021. This acquisition was executed through the issuance of 9,40,232 equity shares.

In 2024, Company has started Srinagar Centre in Jammu & Kashmir; started Banglore Centre in Karnataka.

The Company offer a complete specialized fertility and reproductive health services. The advance treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction, all our treatment is carefully designed to address a variety of infertility challenges for both male and female. It also offers comprehensive gynecological care, including PCOD/PCOS and endometriosis. Further, high-risk pregnancy management is provided for women with complex fertility histories or health conditions. The wellness aspect includes fertility wellness programs, offering nutritional counselling and psychological support to ensure holistic care for couples undergoing treatments.

Apart from these, the facilities provide a comprehensive range of male infertility treatments, including advanced sperm retrieval techniques. For fertility preservation, Company offer cryopreservation services for eggs freezing for future fertilization, utilizing state-of-the-art technology to ensure optimal success rates in future IVF cycles. Additionally, the centers specialize in Frozen Embryo Transfers (FET). They also offer laparoscopic and hysteroscopic surgeries for diagnosis and treatment of infertility-related conditions, as well as genetic testing options, including Preimplantation Genetic Testing (PGT), designed to enhance pregnancy outcomes and mitigate the risks of genetic disorders.

The Company came up with IPO of 2,08,86,200 equity shares of Rs 5 each by raising funds aggregating to Rs 165 crores, comprising a fresh issue of 1,13,92,500 equity shares amounting to Rs 90 crores and the offer for sale of 94,93,700 equity shares amounting to Rs 75 crores on February 24, 2026.

Parent organization Indian Private
NSE symbol GAUDIUMIVF
Founded 2015
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Gaudium IVF and Women Health Ltd?

Answer Field

Gaudium IVF and Women Health Ltd share price is for NSE ₹ 96.91 & for BSE ₹ 97.22 as on Apr 17 2026 03:30 PM.

What is the Market Cap of Gaudium IVF and Women Health Ltd Share?

Answer Field

The market cap of Gaudium IVF and Women Health Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Apr 17 2026 03:30 PM.

What is the 52 Week High and Low of Gaudium IVF and Women Health Ltd?

Answer Field

The 52 Week High and Low of Gaudium IVF and Women Health Ltd for NSE is ₹ 108.00 and ₹ 69.18 and for BSE is ₹ 108.00 and ₹ 69.50.

What is 1 year return for Gaudium IVF and Women Health Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Gaudium IVF and Women Health Ltd Share?

Answer Field

As on Apr 17 2026 03:30 PM the price-to-earnings (PE) ratio for Gaudium IVF and Women Health Ltd share is 34.11.

What is the PB ratio of Gaudium IVF and Women Health Ltd Share?

Answer Field

As on Apr 17 2026 03:30 PM, the price-to-book (PB) ratio for Gaudium IVF and Women Health Ltd share is 18.60.

How to Buy Gaudium IVF and Women Health Ltd Share?

Answer Field

You can trade in Gaudium IVF and Women Health Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gaudium IVF and Women Health Ltd Share on Bajaj Broking App?

Answer Field

To buy Gaudium IVF and Women Health Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gaudium IVF and Women Health Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59